524
Views
5
CrossRef citations to date
0
Altmetric
Review

Understanding treatment guidelines with bismuth and non-bismuth quadruple Helicobacter pylori eradication therapies

, ORCID Icon &
Pages 679-687 | Received 11 Feb 2018, Accepted 09 Aug 2018, Published online: 23 Aug 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (5)

Theodore Rokkas & David Y. Graham. (2023) How widespread and convenient H. pylori susceptibility testing will result in pharmacological opportunities. Expert Review of Gastroenterology & Hepatology 17:1, pages 1-7.
Read now
Yongkang Lai, Wei Wei, Yiqi Du, Jie Gao & Zhaoshen Li. (2022) Biomaterials for Helicobacter pylori therapy: therapeutic potential and future perspectives. Gut Microbes 14:1.
Read now
Jun-Hyung Cho, So Young Jin & Suyeon Park. (2022) Comparison of tailored Helicobacter pylori eradication versus modified bismuth quadruple therapy in Korea: a randomized controlled trial. Expert Review of Anti-infective Therapy 20:6, pages 923-929.
Read now
Rongli Cui, Zhiqiang Song, Baojun Suo, Xueli Tian, Yan Xue, Lingmei Meng, Zhanyue Niu, Zhu Jin, Hejun Zhang & Liya Zhou. (2021) Correlation Analysis Among Genotype Resistance, Phenotype Resistance and Eradication Effect of Helicobacter pylori. Infection and Drug Resistance 14, pages 1747-1756.
Read now
Lyudmila Boyanova, Petyo Hadzhiyski, Nayden Kandilarov, Rumyana Markovska & Ivan Mitov. (2019) Multidrug resistance in Helicobacter pylori: current state and future directions. Expert Review of Clinical Pharmacology 12:9, pages 909-915.
Read now

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.